Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HCC × Radiosurgery × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 12 Lung Neoplasms 10 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Melanoma 3 Liver Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Spinal Cord Neoplasms 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostate Cancer Metastatic 1 Prostate CA 1 Prostate Adenocarcinoma 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1 Mouth Neoplasms 1

Interventions

atezolizumab 1 Radiotherapy 1 Radiosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06823375 2026-03-04

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

Chinese University of Hong Kong

Phase 2 Recruiting

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡